During the past decade, Southwest Cancer Care conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southwest Cancer Care" #1 sponsor was "Telik" with 4 trials, followed by "Celgene" with 3 trials sponsored, "Cascadian Therapeutics Inc." with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "CTI BioPharma" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southwest Cancer Care" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "Smith Kline Beecham" with 1 trials as a collaborator and "US Oncology Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Southwest Cancer Care" are "Ovarian Neoplasms" (3 trials), "Lung Cancer" (2 trials), "Lymphoma, Non-Hodgkin" (2 trials), "Metastatic Breast Cancer" (2 trials) and "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Southwest Cancer Care" in a lesser frequency.

Most popular intervention types in "Southwest Cancer Care" are "Drug" (17 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Ixabepilone" (2 trials), "quality-of-life assessment" (2 trials), "Albumin-bound paclitaxel" (1 trials) and "Bortezomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southwest Cancer Care" are 13 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Southwest Cancer Care". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Southwest Cancer Care, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Southwest Cancer Care, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".